ERAVACYCLINE DIHYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for eravacycline dihydrochloride and what is the scope of patent protection?
Eravacycline dihydrochloride
is the generic ingredient in one branded drug marketed by Tetraphase Pharms and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Eravacycline dihydrochloride has eighty patent family members in thirty-three countries.
One supplier is listed for this compound.
Summary for ERAVACYCLINE DIHYDROCHLORIDE
International Patents: | 80 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Clinical Trials: | 11 |
Patent Applications: | 4 |
DailyMed Link: | ERAVACYCLINE DIHYDROCHLORIDE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ERAVACYCLINE DIHYDROCHLORIDE
Generic Entry Date for ERAVACYCLINE DIHYDROCHLORIDE*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for ERAVACYCLINE DIHYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
West Virginia University | Phase 2 |
Tetraphase Pharmaceuticals, Inc. | Phase 3 |
Tetraphase Pharmaceuticals, Inc. | Phase 1 |
Pharmacology for ERAVACYCLINE DIHYDROCHLORIDE
Drug Class | Tetracycline-class Antibacterial |
US Patents and Regulatory Information for ERAVACYCLINE DIHYDROCHLORIDE
International Patents for ERAVACYCLINE DIHYDROCHLORIDE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 603568 | C7-fluoro substituted tetracycline compounds | ⤷ Try a Trial |
Canada | 2732883 | COMPOSES DE TETRACYCLINE C7-FLUOROSUBSTITUEE (C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS) | ⤷ Try a Trial |
Israel | 211120 | תרכובת, טטראציקלין מותמרת בעמדה 7c עם פלואור, תכשיר רוקחות המכיל אותה ושימוש בה להכנת תרופות לטיפול בזיהום הנגרם על ידי בקטריה (C7-fluoro substituted tetracycline compound, pharmaceutical composition comprising it and its use in the manufacture of medicaments for treating infection caused by bacteria) | ⤷ Try a Trial |
Serbia | 54485 | C7-FLUORO SUPSTITUISANA TETRACIKLINSKA JEDINJENJA (C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS) | ⤷ Try a Trial |
South Korea | 20110058800 | C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS | ⤷ Try a Trial |
Hong Kong | 1193412 | -氟取代的四環素化合物 (C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS C7-) | ⤷ Try a Trial |
South Korea | 101679023 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ERAVACYCLINE DIHYDROCHLORIDE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2323972 | CA 2019 00009 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/18/1312 20180209 |
2323972 | SPC/GB19/017 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK PLGB 24626/0005 20180924; UK PLGB 24626/0006 20180924; UK EU/1/18/1312 (NI) 20180924 |
2323972 | C20190009 00277 | Estonia | ⤷ Try a Trial | PRODUCT NAME: ERAVATSUEKLIIN;REG NO/DATE: EU/1/18/1312 24.09.2018 |
2323972 | CR 2019 00009 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/18/1312 20180209 |
2323972 | LUC00107 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/18/1312 20180924 |
2323972 | 19C1012 | France | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/18/1312 20180924 |
2323972 | 715 | Finland | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.